West Pharmaceutical Services, Inc. (WST)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 01:41PM EDT. Market open.
| Previous close | 368.18 |
| Open | 364.22 |
| Bid | 360.39 x 800 |
| Ask | 360.86 x 800 |
| Day's range | 359.76 - 370.00 |
| 52-week range | 310.42 - 415.73 |
| Volume | |
| Avg. volume | 544,422 |
| Market cap | 26.478B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 47.72 |
| EPS (TTM) | 7.58 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | 0.80 (0.22%) |
| Ex-dividend date | 31 Jul 2024 |
| 1y target est | 403.29 |
Simply Wall St.West Pharmaceutical Services First Quarter 2024 Earnings: Beats Expectations
West Pharmaceutical Services ( NYSE:WST ) First Quarter 2024 Results Key Financial Results Revenue: US$695.4m (down...
- GuruFocus.com
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Despite a dip in Q1 performance, West Pharmaceutical projects a robust year with strategic expansions and improved guidance.
ZacksWest Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
West Pharmaceutical's (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
© 2024 Yahoo. All rights reserved.